Chiral chemistry at Symeres
We apply all state-of-the-art-chiral technologies to obtain the desired compound in high enantiomeric purity.
Photochemistry at Symeres
Through photochemistry, a plethora of, until recently, ‘forbidden’ reactions are successfully applied to the development of new modalities and scaffolds
Symeres acquires Exemplify BioPharma, further strengthening its strategic foothold in the US
Symeres announces the acquisition of Exemplify BioPharma, a US based CRO. Read full press release.
Symeres to host final of Dutch Chemistry Olympiad 2025
Symeres will be the proud host of the final of the Dutch Chemistry Olympiad 2025.
An interview with Anu Mahadevan and Paul Blundell
An interview with the heads of Symeres’ daughter company Organix.
Dr Laszlo Szilagyi joins Symeres to support our EU and APAC activities.
Laszlo is familiar with pharma sales and business development and spent 9 years in different sales head positions.
Expansion of Solid State Center of Excellence
We are doubling our solid state chemistry capacity. Click here to read about what this means for you.
Expanding GMP production capabilities in Prague: Getting ready for the future!
Our GMP-certified development and manufacturing site in Prague is more than doubling in size.
Site-specific alkylations of a glucose derivative in continuous flow
The investigation of a continuous-flow method to scale up carbohydrate scaffold precursors synthesis.
